Adrian Woolfson
Director/Board Member at ImmunoSCAPE Pte Ltd.
Profile
Adrian Woolfson is currently the Director at ImmunoSCAPE Pte Ltd.
He previously worked as the Head-Global Clinical at Pfizer Inc. from 2015 to 2018, as the Executive Vice President-Research & Development at Sangamo Therapeutics, Inc. from 2019 to 2020, and as the Chief Medical Officer at Nouscom AG in 2018.
Dr. Woolfson received his undergraduate degree from the University of Oxford in 1995 and his doctorate degree from the University of Cambridge in 1992.
Adrian Woolfson active positions
| Companies | Position | Start |
|---|---|---|
ImmunoSCAPE Pte Ltd.
 ImmunoSCAPE Pte Ltd. BiotechnologyHealth Technology ImmunoSCAPE Pte Ltd. develops immunotherapy and leveraging therapies. The firm focuses on immunotherapy and leveraging a unique high-dimensional immune profiling Platform. The company was founded by Choon-Peng Ng, Alessandra Nardin, Michael Fehlings and Evan Newell in 2016 and is headquartered in Singapore. | Director/Board Member | 2021-07-27 |
Former positions of Adrian Woolfson
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-06-23 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | 2018-10-31 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
Training of Adrian Woolfson
| University of Oxford | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
ImmunoSCAPE Pte Ltd.
ImmunoSCAPE Pte Ltd. BiotechnologyHealth Technology ImmunoSCAPE Pte Ltd. develops immunotherapy and leveraging therapies. The firm focuses on immunotherapy and leveraging a unique high-dimensional immune profiling Platform. The company was founded by Choon-Peng Ng, Alessandra Nardin, Michael Fehlings and Evan Newell in 2016 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- Adrian Woolfson
